Center for Biologics Evaluation and Research
The Center for Biologics Evaluation and Research is one of six main centers for the U.S. Food and Drug Administration, which is a part of the U.S. Department of Health and Human Services. The current Director of CBER is Vinay Prasad, M.D., M.P.H. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Center for Biologics Evaluation and Research, United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
58%
Total
Publications
5K
Total Open
Publications
2.9K
Total
Citations
249K
Open Access
Percentage
58%
Total
Publications
5K
Total Open
Publications
2.9K
Total
Citations
249K
Breakdown
Publisher Open
15%
Both
33%
Other Platform Open
10%
Closed
42%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 59%
1.4K
Hybrid 14%
341
No Guarantees 27%
673
Other Platform Open
Domain 68%
1.5K
Other Internet 31%
686
Institution 14%
304
Preprint 5%
110
Public 5%
105
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 1.5K |
DOI | Other Internet | 693 |
Office of Scientific and Technical Information | Institution | 157 |
Europe PMC | Domain | 105 |
Figshare | Public | 94 |
bioRxiv | Preprint | 72 |
medRxiv | Preprint | 29 |
Royal Netherlands Academy of Arts and Sciences | Institution | 28 |
Middle East Technical University | Institution | 20 |
Harvard University | Institution | 13 |